384 related articles for article (PubMed ID: 24497837)
1. Comprehensive functional annotation of 77 prostate cancer risk loci.
Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive functional annotation of seventy-one breast cancer risk Loci.
Rhie SK; Coetzee SG; Noushmehr H; Yan C; Kim JM; Haiman CA; Coetzee GA
PLoS One; 2013; 8(5):e63925. PubMed ID: 23717510
[TBL] [Abstract][Full Text] [Related]
3. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
[TBL] [Abstract][Full Text] [Related]
4. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
[TBL] [Abstract][Full Text] [Related]
5. On the identification of potential regulatory variants within genome wide association candidate SNP sets.
Chen CY; Chang IS; Hsiung CA; Wasserman WW
BMC Med Genomics; 2014 Jun; 7():34. PubMed ID: 24920305
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
Jin HJ; Jung S; DebRoy AR; Davuluri RV
Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
[TBL] [Abstract][Full Text] [Related]
8. Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites.
Bu H; Narisu N; Schlick B; Rainer J; Manke T; Schäfer G; Pasqualini L; Chines P; Schweiger MR; Fuchsberger C; Klocker H
Hum Mutat; 2016 Jan; 37(1):52-64. PubMed ID: 26411452
[TBL] [Abstract][Full Text] [Related]
9. In-silico identification and functional validation of allele-dependent AR enhancers.
Garritano S; Romanel A; Ciribilli Y; Bisio A; Gavoci A; Inga A; Demichelis F
Oncotarget; 2015 Mar; 6(7):4816-28. PubMed ID: 25693204
[TBL] [Abstract][Full Text] [Related]
10. Allele-specific enhancers mediate associations between LCAT and ABCA1 polymorphisms and HDL metabolism.
Howard AD; Wang X; Prasad M; Sahu AD; Aniba R; Miller M; Hannenhalli S; Chang YC
PLoS One; 2019; 14(4):e0215911. PubMed ID: 31039173
[TBL] [Abstract][Full Text] [Related]
11. Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues.
Chen H; Kichaev G; Bien SA; MacDonald JW; Wang L; Bammler TK; Auer P; Pasaniuc B; Lindström S
Hum Genet; 2019 Oct; 138(10):1091-1104. PubMed ID: 31230194
[TBL] [Abstract][Full Text] [Related]
12. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
[TBL] [Abstract][Full Text] [Related]
13. Identification of breast cancer associated variants that modulate transcription factor binding.
Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic insights into genetic susceptibility to prostate cancer.
Tian P; Zhong M; Wei GH
Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
[TBL] [Abstract][Full Text] [Related]
15. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
Zhang P; Tillmans LS; Thibodeau SN; Wang L
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
[TBL] [Abstract][Full Text] [Related]
16. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
[TBL] [Abstract][Full Text] [Related]
17. Post genome-wide association studies functional characterization of prostate cancer risk loci.
Jiang J; Cui W; Vongsangnak W; Hu G; Shen B
BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S9. PubMed ID: 24564736
[TBL] [Abstract][Full Text] [Related]
18. Functional mapping of androgen receptor enhancer activity.
Huang CF; Lingadahalli S; Morova T; Ozturan D; Hu E; Yu IPL; Linder S; Hoogstraat M; Stelloo S; Sar F; van der Poel H; Altintas UB; Saffarzadeh M; Le Bihan S; McConeghy B; Gokbayrak B; Feng FY; Gleave ME; Bergman AM; Collins C; Hach F; Zwart W; Emberly E; Lack NA
Genome Biol; 2021 May; 22(1):149. PubMed ID: 33975627
[TBL] [Abstract][Full Text] [Related]
19. Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.
Lu Y; Zhang Z; Yu H; Zheng SL; Isaacs WB; Xu J; Sun J
Prostate; 2011 Jun; 71(9):955-63. PubMed ID: 21541972
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci.
Yan H; Tian S; Kleinstern G; Wang Z; Lee JH; Boddicker NJ; Cerhan JR; Kay NE; Braggio E; Slager SL
Hum Mol Genet; 2020 Sep; 29(16):2761-2774. PubMed ID: 32744316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
